Thus, it there seems to be some relationship between this parameter and breast cancer, but, to accurately determine the impact of this chemokine in diagnosis, it is necessary to determine the CXCL1 concentrations in patients with breast pathologies and healthy women on a larger and more diverse group of patients. This evidence concerns the gene CXCL1 and breast carcinoma.